---
figid: PMC7913870__cancers-13-00611-g003
figtitle: Therapeutic targets to reactivate the Hippo pathway
organisms:
- Saccharomyces cerevisiae
- Lareunionomyces loeiensis
- Spinacia oleracea
- Homo sapiens
- Drosophila melanogaster
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
- Danio rerio
pmcid: PMC7913870
filename: cancers-13-00611-g003.jpg
figlink: pmc/articles/PMC7913870/figure/cancers-13-00611-f003/
number: F3
caption: Potential therapeutic targets to reactivate the Hippo pathway. Modulation
  of upstream kinases STK3/4 and LATS1/2 occurs via post-translational modifications
  and transcriptional regulation. In cancer, a number of these molecules responsible
  for this regulation are altered. Molecules can be mutated (orange), overexpressed
  (red) or lost (grey) to result in high turnover or transcriptional silencing. This
  turns off the Hippo signalling cascade, allowing effector proteins, YAP/TAZ, to
  enter the nucleus and activate gene transcription, resulting in higher cell proliferation,
  cell cycle modulation, expression of other oncogenes such as c-Myc and AR and prevention
  of apoptosis, to name but a few processes.
papertitle: 'Targeting the Hippo Pathway in Prostate Cancer: Whatâ€™s New?.'
reftext: Kelly Coffey. Cancers (Basel). 2021 Feb;13(4):611.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9280296
figid_alias: PMC7913870__F3
figtype: Figure
redirect_from: /figures/PMC7913870__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7913870__cancers-13-00611-g003.html
  '@type': Dataset
  description: Potential therapeutic targets to reactivate the Hippo pathway. Modulation
    of upstream kinases STK3/4 and LATS1/2 occurs via post-translational modifications
    and transcriptional regulation. In cancer, a number of these molecules responsible
    for this regulation are altered. Molecules can be mutated (orange), overexpressed
    (red) or lost (grey) to result in high turnover or transcriptional silencing.
    This turns off the Hippo signalling cascade, allowing effector proteins, YAP/TAZ,
    to enter the nucleus and activate gene transcription, resulting in higher cell
    proliferation, cell cycle modulation, expression of other oncogenes such as c-Myc
    and AR and prevention of apoptosis, to name but a few processes.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EZH2
  - ALK
  - PTK2
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - STK4
  - STK3
  - STK24
  - LATS1
  - LATS2
  - YAP1
  - TAFAZZIN
  - WWTR1
  - TEAD1
  - TEAD2
  - TEAD3
  - TEAD4
  - SAV1
  - SGMS1
  - MOB2
  - MOB3A
  - MOB3B
  - MOB3C
  - MOB4
  - MOB1A
  - MOB1B
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - HSPB1
  - HSPB2
  - IKBKE
  - PPM1F
  - ELL
  - EPB41
  - YWHAQ
  - FRY
  - E(z)
  - Alk
  - Fak
  - Act5C
  - Act42A
  - Act57B
  - Act79B
  - Act88F
  - Act87E
  - Low
  - wts
  - yki
  - Taz
  - Dis3
  - sd
  - sav
  - mats
  - Oamb
  - Hsp27
  - CycE
  - cyc
  - Su(Tpl)
  - 14-3-3zeta
  - 14-3-3epsilon
  - fry
  - fru
  - ezh2
  - alk
  - ltk
  - ptk2ab
  - gdf5
  - stk3
  - lats1
  - lats2
  - tafazzin
  - hspb1
  - ikbke
  - ell
---
